{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:51:25Z","timestamp":1794441085079,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007816","name":"Alcon Laboratories Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ophtha.2025.09.018","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T02:18:27Z","timestamp":1759285107000},"page":"563-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1534-554X","authenticated-orcid":false,"given":"Guruprasad R.","family":"Pattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wirta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Jerkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Paauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene B.","family":"McLaurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Kenyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Cline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeya K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Senchyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ophtha.2025.09.018_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2025.09.018_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajo.2025.05.033","article-title":"TFOS DEWS III diagnostic methodology","volume":"279","author":"Wolffsohn","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2025.09.018_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ophtha.2025.09.018_bib4","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/j.1755-3768.2010.02082.x","article-title":"A comparison of basal and eye-flush tears for the analysis of cat tear proteins","volume":"89","author":"Petznick","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.09.018_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2013.10.008","article-title":"Complexity of the tear film: importance in homeostasis and dysfunction during disease","volume":"117","author":"Dartt","year":"2013","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.ophtha.2025.09.018_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ophtha.2025.09.018_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2021.11.004","article-title":"Efficacy and safety of OC-01 (varenicline solution) nasal spray on signs and symptoms of dry eye disease: The ONSET-2 phase 3 randomized trial","volume":"129","author":"Wirta","year":"2022","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2025.09.018_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jtos.2018.11.002","article-title":"Neurostimulation in dry eye disease-past, present, and future","volume":"17","author":"Dieckmann","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2025.09.018_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2025.09.018_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.exer.2013.08.011","article-title":"The role of corneal afferent neurons in regulating tears under normal and dry eye conditions","volume":"117","author":"Meng","year":"2013","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.ophtha.2025.09.018_bib11","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1167\/iovs.09-4744","article-title":"Cold-sensitive corneal afferents respond to a variety of ocular stimuli central to tear production: implications for dry eye disease","volume":"51","author":"Hirata","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ophtha.2025.09.018_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1152\/jn.00657.2011","article-title":"Ocular dryness excites two classes of corneal afferent neurons implicated in basal tearing in rats: involvement of transient receptor potential channels","volume":"107","author":"Hirata","year":"2012","journal-title":"J Neurophysiol"},{"issue":"1","key":"10.1016\/j.ophtha.2025.09.018_bib13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtos.2018.11.009","article-title":"Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: results from two pivotal clinical trials","volume":"17","author":"Sheppard","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2025.09.018_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtos.2022.05.001","article-title":"Nicotinic acetylcholine receptor stimulation: a new approach for stimulating tear secretion in dry eye disease","volume":"25","author":"Pflugfelder","year":"2022","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.ophtha.2025.09.018_bib15","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1167\/iovs.09-5119","article-title":"Cold thermoreceptors, unexpected players in tear production and ocular dryness sensations","volume":"52","author":"Belmonte","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2025.09.018_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf"},{"issue":"12","key":"10.1016\/j.ophtha.2025.09.018_bib17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/nm.2264","article-title":"Ocular surface wetness is regulated by TRPM8-dependent cold thermoreceptors of the cornea","volume":"16","author":"Parra","year":"2010","journal-title":"Nat Med"},{"issue":"6876","key":"10.1016\/j.ophtha.2025.09.018_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature719","article-title":"Identification of a cold receptor reveals a general role for TRP channels in thermosensation","volume":"416","author":"McKemy","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ophtha.2025.09.018_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(02)00652-9","article-title":"A TRP channel that senses cold stimuli and menthol","volume":"108","author":"Peier","year":"2002","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ophtha.2025.09.018_bib20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ceca.2007.03.005","article-title":"Characterisation of TRPM8 as a pharmacophore receptor","volume":"42","author":"Bodding","year":"2007","journal-title":"Cell Calcium"},{"issue":"3","key":"10.1016\/j.ophtha.2025.09.018_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ceca.2006.07.002","article-title":"Prospects for prostate cancer imaging and therapy using high-affinity TRPM8 activators","volume":"41","author":"Beck","year":"2007","journal-title":"Cell Calcium"},{"issue":"4","key":"10.1016\/j.ophtha.2025.09.018_bib22","first-page":"370","article-title":"Menthol derivative WS-12 selectively activates transient receptor potential melastatin-8 (TRPM8) ion channels","volume":"21","author":"Sherkheli","year":"2008","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.ophtha.2025.09.018_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jtos.2022.08.003","article-title":"A randomized, vehicle-controlled, phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1)","volume":"26","author":"Wirta","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2025.09.018_bib24","series-title":"AR-15512: a novel TRPM8 agonist for the treatment of the signs and symptoms of dry eye: phase 3 pivotal study results. Paper presented at: AAO Annual","author":"Wirta","year":"2024"},{"key":"10.1016\/j.ophtha.2025.09.018_bib25","unstructured":"Whitley WK, Nichols KK, Evans D, et al. Tear production associated with a novel TRPM8 agonist (AR-15512): results from phase 3 pivotal clinical studies (COMET-2 and COMET-3). Paper presented at: American Academy of Optometry Academy 2024; November 6-9, 2024; Indianapolis, IN."},{"issue":"1","key":"10.1016\/j.ophtha.2025.09.018_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","article-title":"Development and validation of a short global dry eye symptom index","volume":"5","author":"Schaumberg","year":"2007","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.ophtha.2025.09.018_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40123-017-0110-x","article-title":"Use of the Controlled Adverse Environment (CAE) in clinical research: a review","volume":"6","author":"Ousler GW 3rd","year":"2017","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.ophtha.2025.09.018_bib29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jtos.2017.05.009","article-title":"TFOS DEWS II clinical trial design report","volume":"15","author":"Novack","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ophtha.2025.09.018_bib30","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s40123-023-00720-1","article-title":"Possible strategies to mitigate placebo or vehicle response in dry eye disease trials: a narrative review","volume":"12","author":"Montecchi-Palmer","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"10.1016\/j.ophtha.2025.09.018_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2023.102048","article-title":"Diagnosing dry-eye: which tests are most accurate?","volume":"46","author":"Papas","year":"2023","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.ophtha.2025.09.018_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1167\/iovs.05-0380","article-title":"Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca","volume":"47","author":"Suwan-Apichon","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ophtha.2025.09.018_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/ICO.0b013e318033a729","article-title":"Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress","volume":"26","author":"Corrales","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2025.09.018_bib34","first-page":"250","article-title":"Inflammatory cytokine expression on the ocular surface in the Botulinum toxin B induced murine dry eye model","volume":"15","author":"Zhu","year":"2009","journal-title":"Mol Vis"},{"issue":"4","key":"10.1016\/j.ophtha.2025.09.018_bib35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/1120672118791936","article-title":"Safety and tolerability of lifitegrast ophthalmic solution 5.0%: pooled analysis of five randomized controlled trials in dry eye disease","volume":"29","author":"Nichols","year":"2019","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2025.09.018_bib36","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamaophthalmol.2023.0709","article-title":"Efficacy and safety of a water-free topical cyclosporine, 0.1%, solution for the treatment of moderate to severe dry eye disease: the ESSENCE-2 randomized clinical trial","volume":"141","author":"Akpek","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2025.09.018_bib37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ophtha.2022.12.021","article-title":"NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI study","volume":"130","author":"Tauber","year":"2023","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ophtha.2025.09.018_bib38","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.pain.2013.06.043","article-title":"TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain","volume":"154","author":"Liu","year":"2013","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.ophtha.2025.09.018_bib39","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1167\/iovs.03-1366","article-title":"Tear secretion induced by selective stimulation of corneal and conjunctival sensory nerve fibers","volume":"45","author":"Acosta","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ophtha.2025.09.018_bib40","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/cne.24454","article-title":"Morphological and functional changes in TRPM8-expressing corneal cold thermoreceptor neurons during aging and their impact on tearing in mice","volume":"526","author":"Alcalde","year":"2018","journal-title":"J Comp Neurol"},{"issue":"9","key":"10.1016\/j.ophtha.2025.09.018_bib41","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1152\/jn.00523.2012","article-title":"Quantitative characterization reveals three types of dry-sensitive corneal afferents: pattern of discharge, receptive field, and thermal and chemical sensitivity","volume":"108","author":"Hirata","year":"2012","journal-title":"J Neurophysiol"},{"issue":"41","key":"10.1016\/j.ophtha.2025.09.018_bib42","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1523\/JNEUROSCI.0654-19.2019","article-title":"Role of TRPM8 channels in altered cold sensitivity of corneal primary sensory neurons induced by axonal damage","volume":"39","author":"Pina","year":"2019","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.ophtha.2025.09.018_bib43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1167\/iovs.16-20033","article-title":"Functional properties of sensory nerve terminals of the mouse cornea","volume":"58","author":"Gonzalez-Gonzalez","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ophtha.2025.09.018_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/j.pain.0000000000000455","article-title":"Abnormal activity of corneal cold thermoreceptors underlies the unpleasant sensations in dry eye disease","volume":"157","author":"Kovacs","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.ophtha.2025.09.018_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ajo.2023.03.008","article-title":"NOV03 for signs and symptoms of dry eye disease associated with meibomian gland dysfunction: the randomized phase 3 MOJAVE study","volume":"252","author":"Sheppard","year":"2023","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025006050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025006050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:11:15Z","timestamp":1792804275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642025006050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0161642025006050"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.09.018","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology\u00e9","name":"copyright","label":"Copyright"}]}}